Assessing the Impact of Probiotic Supplementation in Children Diagnosed With Autism Spectrum Disorder: the PROBI-O-TISM Study

NANot yet recruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

Three strains of Lactobacillus: L. acidophilus CL1285®, L. casei LBC80R® and L. rhamnosus CLR2®

A probiotic beverage (98 g) at dose of 50.10\^9 CFU, taken once daily for 14 weeks.

OTHER

Placebo

Non fermented beverage (98 g) with no probiotic strains, taken once daily for 14 weeks.

Trial Locations (1)

H3T 1C5

CHU Sainte-Justine, Montreal

All Listed Sponsors
collaborator

Hôpital du Sacré-Coeur de Montréal (CIUSSS - NIM)

UNKNOWN

collaborator

University of Ottawa

OTHER

collaborator

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

OTHER

collaborator

Institut National de la Recherche Scientifique - Centre Armand Frappier Santé Biotechnologie

UNKNOWN

lead

Valérie Marcil

OTHER

NCT06906068 - Assessing the Impact of Probiotic Supplementation in Children Diagnosed With Autism Spectrum Disorder: the PROBI-O-TISM Study | Biotech Hunter | Biotech Hunter